Lifetime Prevalence of Cervical Cancer Screening in 55 Low- and Middle-Income Countries

Julia M. Lemp, Jan‐Walter De Neve, Hermann Bussmann, Simiao Chen, Jennifer Manne‐Goehler, Michaela Theilmann, Maja E. Marcus, Cara Ebert, Charlotte Probst, Lindiwe Tsabedze-Sibanyoni, Lela Sturua, Joseph Kibachio, Sahar Saeedi Moghaddam, João Martins, Dismand Stéphan Houinato, Corine Houéhanou, Mongal Singh Gurung, Gladwell Gathecha, Farshad Farzadfar, Scott Dryden‐Peterson, Justine Davies, Rifat Atun, Sebastián Vollmer, Till Bärnighausen, Pascal Geldsetzer

JAMA, 2020

Heidelberg University, University Hospital Heidelberg, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Massachusetts General Hospital, Harvard University, Brigham and Women's Hospital, University of Göttingen, RWI – Leibniz Institute for Economic Research, Centre for Addiction and Mental Health, Ministry of Health, National Center for Disease Control and Public Health, Ministry of Health, University of Geneva, Tehran University of Medical Sciences, Universidade da Paz, Université d'Abomey-Calavi, Botswana Harvard AIDS Institute Partnership, University of Birmingham, University of the Witwatersrand, Harvard Global Health Institute, Africa Health Research Institute, Stanford University

View Free PDF Publisher Website

Abstract

This research paper explore the methodology and findings associated with JAMA. The study delves into the core aspects of the research field, providing significant data and citation impact. (Full abstract processing is available via the OpenAlex API).

184

Citations

View on Google Scholar

Lifetime Prevalence of Cervical Cancer Screening in 55 Low- and Middle-Income Countries

Abstract

Journal Details

Join JournalsHub

Welcome Back